home / openregs

legislation

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,419 rows where congress = 114 and policy_area = "Health" sorted by introduced_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: origin_chamber, sponsor_party, introduced_date (date), latest_action_date (date), update_date (date)

bill_type 6

  • hr 780
  • s 441
  • hres 106
  • sres 82
  • hconres 8
  • hjres 2

policy_area 1

  • Health · 1,419 ✖

congress 1

  • 114 · 1,419 ✖
bill_id congress bill_type bill_number title policy_area introduced_date ▲ latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
114-hjres-108 114 hjres 108 Disapproving a rule submitted by the Department of Health and Human Services relating to "Compliance with Title X Requirements by Project Recipients in Selecting Subrecipients". Health 2016-12-20 2016-12-20 Referred to the House Committee on Energy and Commerce. House Rep. Messer, Luke [R-IN-6] IN R M001189 0 Nullifies a Department of Health and Human Services rule regarding subrecipients of family planning grants. (Under the rule, grant recipients may prohibit an entity from receiving a subaward only for reasons related to the entity's ability to provide family planning services.) 2023-01-11T13:33:57Z  
114-hres-956 114 hres 956 Honoring the Life and Legacy of Phil Smith. Health 2016-12-20 2016-12-20 Referred to the House Committee on Oversight and Government Reform. House Rep. Hastings, Alcee L. [D-FL-20] FL D H000324 5 Honors the life and accomplishments of Phil Smith. Offers condolences to Phil Smith's family and friends. Commends Phil Smith's philanthropic efforts and recognizes his impact on South Florida. 2023-01-11T13:33:52Z  
114-s-3548 114 s 3548 A bill to continue the Medicaid emergency psychiatric demonstration project. Health 2016-12-10 2016-12-10 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Cardin, Benjamin L. [D-MD] MD D C000141 3 This bill: (1) continues the Medicaid emergency psychiatric demonstration project; (2) authorizes the Centers for Medicare & Medicaid Services to replace with another state, on a competitive basis, any originally selected state that elects not to resume its participation in the project; and (3) modifies other requirements related to the project. 2023-01-11T13:34:42Z  
114-sres-636 114 sres 636 A resolution designating the week of December 4 through December 10, 2016, as "National Nurse-Managed Health Clinic Week". Health 2016-12-10 2016-12-10 Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S7121; text as passed Senate: CR S7037) Senate Sen. Alexander, Lamar [R-TN] TN R A000360 1 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Designates the week of December 4-December 10, 2016, as National Nurse-Managed Health Clinic Week and expresses support for its goals and ideals. Encourages the expansion of nurse-managed health clinics so that they may continue to serve as health care workforce development sites for the next generation of primary care providers. 2018-06-02T06:22:26Z  
114-hr-6501 114 hr 6501 Prescription Drug and Medical Device Price Review Board Act of 2016 Health 2016-12-08 2016-12-22 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. House Rep. DeLauro, Rosa L. [D-CT-3] CT D D000216 8 Prescription Drug and Medical Device Price Review Board Act of 2016 This bill establishes the Prescription Drug and Medical Device Price Review Board within the Food and Drug Administration. Each manufacturer of a prescription drug or medical device that is sold in the United States must submit to the board: each type of prescription drug and medical device that it sells in the United States, or in a country that is a member of the Organization for Economic Co-operation and Development; the price charged by the manufacturer for the drug or device; and the costs of the manufacturer to produce them. The board must establish a formula for determining whether the average manufacturer price of a prescription drug or medical device over an annual quarter is an excessive price. Manufacturers may not charge excessive prices. Individuals may petition the board to determine whether the price for a prescription drug or medical device is excessive. The board may subject violators to reduced patent terms, civil penalties, and increased Medicaid rebates. The bill amends the Internal Revenue Code to impose a tax on the sale of prescription drugs or medical devices that have excessive prices. The board must allow individuals to import from approved counties prescription drugs and devices that are comparable to prescription drugs and devices with excessive prices. 2023-01-11T13:33:54Z  
114-hr-6503 114 hr 6503 Care for Life Act Health 2016-12-08 2016-12-08 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Fortenberry, Jeff [R-NE-1] NE R F000449 0 Care for Life Act This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to develop and maintain the Pregnant and Parenting Women's Care Information Service database. This database must provide pregnant women and new parents with information on public and private service providers that help such women and parents in alleviating the physical, financial, social, and emotional difficulties encountered during or after pregnancy. HHS may award grants to: (1) providers to develop best practices for communities to identify optimal ways to provide pregnancy and parenting support services, and (2) academic medical centers to provide specialized training in pregnancy and parenting support services. The Department of Labor must recognize and publicize the practices of employers who successfully meet the needs of their pregnant or parenting employees. The grant program of the Department of Education to improve postsecondary education opportunities is expanded to include funding for the development of an online information toolkit about agencies that are working within institutions of higher education to provide pregnancy and child care services for students. 2023-01-11T13:33:54Z  
114-hr-6512 114 hr 6512 Mental Health and Substance Abuse Treatment Accessibility Act of 2016 Health 2016-12-08 2016-12-08 Referred to the House Committee on Energy and Commerce. House Rep. Kilmer, Derek [D-WA-6] WA D K000381 2 Mental Health and Substance Abuse Treatment Accessibility Act of 2016 This bill amends the Public Health Service Act to permit the Department of Health and Human Services to make loans and loan guarantees for construction or renovation of psychiatric or substance abuse treatment facilities. The bill establishes terms and conditions for these loans and loan guarantees. The bill establishes the Mental Health and Substance Use Treatment Trust Fund. Revenues from the loans and loan guarantees that exceed the cost of carrying out the program may be appropriated to the fund. Amounts in the fund are available for block grants for community mental health services. 2023-01-11T13:33:54Z  
114-hr-6514 114 hr 6514 To amend the Patient Protection and Affordable Care Act to redirect user fees assessed of health insurance issuers on Federal Exchanges, and for other purposes. Health 2016-12-08 2016-12-08 Referred to the House Committee on Energy and Commerce. House Rep. Lance, Leonard [R-NJ-7] NJ R L000567 0 This bill amends the Patient Protection and Affordable Care Act to require the Department of Health and Human Services to deposit monthly in the Treasury $1.50 for each individual enrolled in health insurance coverage though a federally operated health insurance exchange. The user fee charged to health insurers by federally operated health insurance exchanges may not exceed a specified percentage of a plan's premiums. 2023-01-11T13:33:54Z  
114-hr-6515 114 hr 6515 Fairness to Teaching Hospitals Act of 2016 Health 2016-12-08 2016-12-08 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Mullin, Markwayne [R-OK-2] OK R M001190 4 Fairness to Teaching Hospitals Act of 2016 This bill amends the Patient Protection and Affordable Care Act to specify that a certain Medicare rule for counting resident time in nonprovider settings shall not be applied in a manner that requires the reopening of any settled hospital cost reports except where there was a jurisdictionally proper appeal pending as of March 23, 2010. The bill applies retroactively. 2023-01-11T13:33:54Z  
114-hr-6518 114 hr 6518 MACPAC Improvement Act of 2016 Health 2016-12-08 2016-12-08 Referred to the House Committee on Energy and Commerce. House Rep. Pitts, Joseph R. [R-PA-16] PA R P000373 7 MACPAC Improvement Act of 2016 This bill amends title XIX (Medicaid) of the Social Security Act to modify provisions related to the duties, membership, and conflict-of-interest policies of the Medicaid and Children's Health Insurance Plan (CHIP) Payment and Access Commission. 2023-01-11T13:33:54Z  
114-s-3522 114 s 3522 Graduate Medical Education Equity Act Health 2016-12-08 2016-12-08 Read twice and referred to the Committee on Finance. Senate Sen. Whitehouse, Sheldon [D-RI] RI D W000802 0 Graduate Medical Education Equity Act This bill amends title XVIII (Medicare) of the Social Security Act to allow a qualified hospital to have its payment amount for direct graduation medical education costs calculated on the basis of its Medicaid inpatient utilization rate rather than on the basis of its Medicare patient load. 2023-01-11T13:34:43Z  
114-s-3530 114 s 3530 Ensuring Patient Access to Healthcare Records Act of 2016 Health 2016-12-08 2016-12-08 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Cassidy, Bill [R-LA] LA R C001075 0 Ensuring Patient Access to Healthcare Records Act of 2016 This bill amends the Health Information Technology for Economic and Clinical Health Act to require the Department of Health and Human Services to develop and update policies that enable certain health care clearinghouses, plans, and providers to: (1) provide patients with access to information related to their care; and (2) develop patient-engagement tools, reports, analyses, and presentations that may demonstrate benefit to the taxpayer. 2023-01-11T13:34:43Z  
114-hr-6457 114 hr 6457 Preventive Services Medicare Parity Act of 2016 Health 2016-12-07 2016-12-07 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Veasey, Marc A. [D-TX-33] TX D V000131 0 Preventive Services Medicare Parity Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to: (1) provide for Medicare coverage of certain preventive services for which coverage is required by group and individual health insurance plans, and (2) revise the authority of the Centers for Medicare & Medicaid Services to use the process for making national coverage determinations with respect to determining coverage of additional preventive services. 2023-01-11T13:33:56Z  
114-hr-6462 114 hr 6462 Prioritizing the Most Vulnerable Americans Act Health 2016-12-07 2016-12-07 Referred to the House Committee on Energy and Commerce. House Rep. Collins, Chris [R-NY-27] NY R C001092 5 Prioritizing the Most Vulnerable Medicaid Patients This bill amend title XI (General Provisions) of the Social Security Act to require the Centers for Medicare & Medicaid Services, in approving Medicaid demonstration projects, to: prioritize projects that have been proven effective in improving care and outcomes with respect to uninsured, Medicaid-eligible, or low-income individuals; require participating states to make publicly available data regarding the health outcomes for individuals to be served; ensure that projects are not duplicative of any federal program or funding opportunity; and require participating states to make publicly available an analysis of the degree to which such projects preclude private and charitable sector efforts to improve care and outcomes with respect to uninsured, Medicaid-eligible, or low-income individuals.  2023-01-11T13:33:56Z  
114-hr-6463 114 hr 6463 Patient Safety and Toxicology Modernization Act of 2016 Health 2016-12-07 2016-12-07 Referred to the House Committee on Energy and Commerce. House Rep. Collins, Chris [R-NY-27] NY R C001092 1 Patient Safety and Toxicology Modernization Act of 2016 This bill requires the Food and Drug Administration to issue and periodically update guidance on: (1) novel tools for testing the toxicology and efficacy of medications, and (2) three-dimensional human tissue models. 2023-01-11T13:33:55Z  
114-s-3519 114 s 3519 Trauma-Informed Care for Children and Families Act of 2016 Health 2016-12-07 2016-12-07 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Heitkamp, Heidi [D-ND] ND D H001069 2 Trauma-Informed Care for Children and Families Act of 2016 This bill amends the Public Health Service Act, the Elementary and Secondary Education Act of 1965, title XIX (Medicaid) of the Social Security Act, and other laws to:  establish the Interagency Task Force on Trauma-Informed Care; support the National Child Traumatic Stress Initiative; establish the National Law Enforcement Child and Youth Trauma Coordinating Center; authorize the Department of Education to award grants for the improvement of trauma support services and mental health care for children in educational settings; establish Medicaid demonstration projects to test innovative, trauma-informed approaches for delivering early and periodic screening, diagnostic, and treatment services to eligible children; modify and extend the Performance Partnership Pilots; and revise or establish provisions related to best practices, data collection, health professional shortage areas, licensing guidelines for certain community figures, health care workforce training, trauma-related coordinating bodies, and trauma-informed teaching. 2023-01-11T13:34:43Z  
114-s-3504 114 s 3504 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2016 Health 2016-12-06 2016-12-06 Read twice and referred to the Committee on Finance. Senate Sen. Hatch, Orrin G. [R-UT] UT R H000338 4 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to: extend the Independence at Home demonstration program; modify provisions regarding access to home dialysis therapy under Medicare and special needs plans under Medicare Advantage (MA); expand testing of the MA Value-Based Insurance Design test model; allow an MA plan to provide additional telehealth benefits to enrollees and, to chronically ill enrollees, certain supplemental health care benefits; modify other provisions regarding the use of telehealth services; allow prospective, voluntary assignment of Medicare fee-for-service beneficiaries to accountable care organizations (ACOs); and allow ACOs to operate beneficiary incentive programs. 2023-01-11T13:34:44Z  
114-hres-941 114 hres 941 Expressing support for the designation of February 22, 2017, as "National Heart Valve Disease Awareness Day", coinciding with American Heart Month. Health 2016-12-05 2016-12-05 Referred to the House Committee on Energy and Commerce. House Rep. Cárdenas, Tony [D-CA-29] CA D C001097 1 Expresses support for: (1) the designation of National Heart Valve Disease Awareness Day, and (2) the efforts of the Department of Health and Human Services and the entire medical community to educate people about heart valve disease. 2023-01-11T13:33:53Z  
114-hr-6428 114 hr 6428 To amend title XVIII of the Social Security Act to limit Medicare part B premium increases for 2017. Health 2016-12-02 2016-12-02 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Titus, Dina [D-NV-1] NV D T000468 43 This bill amends title XVIII (Medicare) of the Social Security Act to limit increases to monthly premiums under Medicare for 2017. Specifically, an individual's monthly premium shall increase by no more than $4 over the individual's monthly premium for 2016. 2023-01-11T13:33:57Z  
114-s-7 114 s 7 Steve Gleason Act of 2016 Health 2016-12-01 2016-12-01 Read twice and referred to the Committee on Finance. Senate Sen. Vitter, David [R-LA] LA R V000127 1 Steve Gleason Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to make permanent the elimination of a specified payment cap under the Medicare program with respect to speech generating devices. 2023-01-11T13:34:42Z  
114-s-9 114 s 9 Over-the-Counter Hearing Aid Act of 2016 Health 2016-12-01 2016-12-01 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Warren, Elizabeth [D-MA] MA D W000817 1 Over-the-Counter Hearing Aid Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to categorize certain hearing aids as over-the-counter hearing aids and issue regulations regarding those hearing aids. The regulations for over-the-counter hearing aids must provide reasonable assurances of safety and efficacy and describe requirements for the sale of hearing aids in-person, by mail, or online, without a prescription. State and local governments may not establish or continue in effect requirements for over-the-counter hearing aids that are not identical to FDA requirements. Until the FDA updates its draft guidance regarding hearing aids, previous draft guidance is in effect. 2023-01-11T13:34:42Z  
114-sres-627 114 sres 627 A resolution designating December 3, 2016, as "National Phenylketonuria Awareness Day". Health 2016-12-01 2016-12-01 Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6681; text as passed Senate: CR S6667) Senate Sen. Isakson, Johnny [R-GA] GA R I000055 1 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Designates December 3, 2016, as National Phenylketonuria Awareness Day. (Phenylketonuria or PKU is a rare, inherited metabolic disorder that can cause intellectual disability and other neurological problems.) 2018-06-02T06:22:22Z  
114-hr-6404 114 hr 6404 Medicare Home Health Flexibility Act of 2016 Health 2016-11-30 2016-11-30 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Boustany, Charles W., Jr. [R-LA-3] LA R B001255 1 Medicare Home Health Flexibility Act of 2016 This bill establishes circumstances under which an occupational therapist may conduct the initial assessment visit for an individual who is eligible for home health services under Medicare. Specifically, an occupational therapist may conduct the assessment if the physician's referral order does not include skilled nursing care but does include: (1) occupational therapy, and (2) physical therapy or speech language pathology. 2023-01-11T13:34:01Z  
114-s-3487 114 s 3487 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016 Health 2016-11-30 2016-11-30 Read twice and referred to the Committee on Finance. Senate Sen. Vitter, David [R-LA] LA R V000127 0 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016 This bill amends titles II (Old Age, Survivors, and Disability Insurance) and XVIII (Medicare) of the Social Security Act to indefinitely extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients. Under current law, such coverage is limited to 36 months following a transplant. 2023-01-11T13:33:58Z  
114-sres-624 114 sres 624 A resolution supporting the goals, activities, and ideals of World Prematurity Month. Health 2016-11-30 2016-11-30 Referred to the Committee on the Judiciary. (text of measure as introduced: CR S6621-6622) Senate Sen. Brown, Sherrod [D-OH] OH D B000944 1 Recognizes November 2016 as World Prematurity Month. Expresses support for efforts to: (1) reduce the impact of preterm births by improving maternal health, and (2) advance the care and treatment of infants who are born preterm. Honors individuals working to reduce the number of preterm births. 2023-01-11T13:33:58Z  
114-sres-625 114 sres 625 A resolution supporting the goals, activities, and ideals of World Prematurity Day. Health 2016-11-30 2016-11-30 Referred to the Committee on the Judiciary. (text of measure as introduced: CR S6622) Senate Sen. Brown, Sherrod [D-OH] OH D B000944 1 Recognizes November 17, 2016, as World Prematurity Day. Expresses support for efforts to: (1) reduce the impact of preterm births by improving maternal health, and (2) advance the care and treatment of infants who are born preterm. Honors individuals working to reduce the number of preterm births. 2023-01-11T13:33:58Z  
114-sres-626 114 sres 626 A resolution recognizing the 75th anniversary of the establishment of the University of Texas MD Anderson Cancer Center in Houston, Texas. Health 2016-11-30 2016-11-30 Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6627-6628; text as passed Senate: CR S6622) Senate Sen. Cornyn, John [R-TX] TX R C001056 1 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Recognizes the 75th anniversary of the establishment of MD Anderson Cancer Center in Houston, Texas. Commends the center and its employees for providing quality care to hundreds of thousands of patients over the last 75 years. 2018-06-02T06:22:22Z  
114-hr-6399 114 hr 6399 Fixing Medicare Hospital Payments Act of 2016 Health 2016-11-29 2016-11-29 Referred to the House Committee on Ways and Means. House Rep. Kelly, Mike [R-PA-3] PA R K000376 1 Fixing Medicare Hospital Payments Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to establish, with respect to calculating payment for inpatient hospital services under Medicare's prospective payment system, a minimum area wage index for hospitals located in metropolitan areas. (Under a prospective payment system, payment is made according to a predetermined, fixed amount.) 2023-01-11T13:34:01Z  
114-sres-621 114 sres 621 A resolution designating November 2016 as National Hospice and Palliative Care Month. Health 2016-11-29 2016-11-29 Referred to the Committee on the Judiciary. (text of measure as introduced: CR S6552) Senate Sen. Wyden, Ron [D-OR] OR D W000779 5 Designates November 2016 as National Hospice and Palliative Care Month. Encourages individuals to increase their understanding and awareness of care at the end of life. 2023-01-11T13:33:58Z  
114-hr-6347 114 hr 6347 To extend for one year the program for priority review to encourage treatments for rare pediatric diseases. Health 2016-11-17 2016-11-17 Referred to the House Committee on Energy and Commerce. House Rep. Grayson, Alan [D-FL-9] FL D G000556 0 This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2017 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.) 2023-01-11T13:34:03Z  
114-hr-6348 114 hr 6348 To extend for two years the program for priority review to encourage treatments for rare pediatric diseases. Health 2016-11-17 2016-11-17 Referred to the House Committee on Energy and Commerce. House Rep. Grayson, Alan [D-FL-9] FL D G000556 0 This bill amends the Federal Food, Drug, and Cosmetic Act to extend through 2018 the priority review voucher program for treatments for rare pediatric diseases. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration within six months.) 2023-01-11T13:34:03Z  
114-hr-6378 114 hr 6378 PATH Fairness Act of 2016 Health 2016-11-17 2016-11-17 Referred to the House Committee on Energy and Commerce. House Rep. Welch, Peter [D-VT-At Large] VT D W000800 1 PATH Fairness Act of 2016 This bill amends the Public Health Service Act to revise and extend Projects for Assistance in Transition from Homelessness, which provide services to individuals who: (1) are suffering from serious mental illness, or are suffering from serious mental illness and from substance abuse; and (2) are homeless or at imminent risk of becoming homeless. The minimum allotment of program funding for each state and territory is increased on the condition that appropriations are sufficient to provide the minimum allotment to all states and territories. 2023-01-11T13:34:02Z  
114-s-3477 114 s 3477 Protecting Seniors Through Immunization Act of 2016 Health 2016-11-17 2016-11-17 Read twice and referred to the Committee on Finance. Senate Sen. Hirono, Mazie K. [D-HI] HI D H001042 1 Protecting Seniors Through Immunization Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to specify that certain deductible, coinsurance, initial coverage limit, and cost-sharing requirements that apply under the Medicare prescription drug benefit shall not apply with respect to the shingles vaccine. The Centers for Medicare & Medicaid Services must provide to Medicare beneficiaries specified information regarding: (1) coverage of vaccines for seniors, and (2) access to the shingles vaccine without cost-sharing. 2023-01-11T13:33:59Z  
114-sres-616 114 sres 616 A resolution supporting the goals and ideals of American Diabetes Month. Health 2016-11-17 2016-11-17 Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6488-6489) Senate Sen. Shaheen, Jeanne [D-NH] NH D S001181 10 Expresses support for: (1) the goals and ideals of American Diabetes Month, including encouraging individuals to fight diabetes through public awareness about prevention and treatment options and enhancing education about the disease; and (2) decreasing the prevalence of type 1, type 2, and gestational diabetes in the United States through increased research, treatment, and prevention. Recognizes the importance of early detection, awareness of the symptoms, and the risk factors that often lead to the development of diabetes. 2023-01-11T13:33:58Z  
114-hr-6333 114 hr 6333 To amend title XVIII of the Social Security Act with respect to the accreditation of osteopathic residency training programs for purposes of graduate medical education payments under the Medicare program. Health 2016-11-16 2016-11-16 Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Kelly, Mike [R-PA-3] PA R K000376 1 This bill amends title XVIII (Medicare) of the Social Security Act to modify, with respect to graduate medical education (GME) payments under the Medicare program, provisions related to "approved medical residency training programs" by: (1) specifying that such programs include osteopathic community residency training programs; and (2) replacing the requirement for such programs to include certain postgraduate training in geriatric medicine with a requirement for approval by a certified accrediting body. Under current law, a "foreign medical graduate" is generally a resident who was not a graduate of a school that meets the standards for accreditation by one of several specified accreditors. (Foreign medical graduates are subject to certain examination requirements for purposes of being counted as residents with respect to Medicare GME payments.) The bill alters this definition such that a "foreign medical graduate" is a resident who is not a graduate of an accredited school. The Centers for Medicare & Medicaid Services must certify at least two accrediting bodies for the purpose of accrediting medical residency training programs in allopathic and osteopathic medicine. 2023-01-11T13:34:03Z  
114-hres-926 114 hres 926 Expressing the sense of the House of Representatives that the President should award the Presidential Medal of Freedom, posthumously, to Mrs. Henrietta Lacks, in recognition of her invaluable contribution to modern science in the form of her own immortal cells-HeLa cells-without which life-saving medicines and procedures would not have been developed at critical moments in our Nation's history. Health 2016-11-16 2016-11-16 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Kelly, Robin L. [D-IL-2] IL D K000385 21 Expresses the sense of the House of Representatives that: (1) the President should award the Presidential Medal of Freedom posthumously to Mrs. Henrietta Lacks in recognition of her invaluable contribution to modern science in the form of her own immortal cells, called HeLa cells; and (2) the case of Mrs. Lacks has spurred the medical and scientific communities to recognize their role in perpetuating racial and socioeconomic bias and has enabled the establishment of greater health care protections for patients. 2023-01-11T13:33:59Z  
114-s-4 114 s 4 Protecting Access to Diabetes Supplies Act of 2016 Health 2016-11-16 2016-11-16 Read twice and referred to the Committee on Finance. Senate Sen. Coats, Daniel [R-IN] IN R C000542 1 Protecting Access to Diabetes Supplies Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to modify provisions relating to Medicare's competitive acquisition program (through which rates are set through a competitive bidding program rather than by an established fee schedule) with respect to diabetic testing strips. Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to: use specified data to determine whether a bid satisfies certain requirements related to volume of coverage with respect to such products, reject a bid if the bidder does not demonstrate its ability to furnish such products in a manner consistent with its bid, and establish a process to monitor the extent to which an entity continues to cover the product types included in its bid. CMS may terminate a contract if it determines that an entity, for reasons other than product discontinuation or market-wide shortage, fails to maintain ready access to such products included its bid. In addition, the bill specifies that an entity furnishing such products to beneficiaries under the program: (1) must furnish to each beneficiary a brand of strips that is compatible with the beneficiary's home blood glucose monitor, (2) may not attempt to influence or incentivize a beneficiary to switch the brand of either type of product, and (3) must contact and receive a request from a beneficiary no more than 14 days prior to dispensing a refill to the beneficiary. 2023-01-11T13:33:58Z  
114-hconres-172 114 hconres 172 Expressing the sense of Congress that public health professionals should be commended for their dedication and continued service to the United States on "Public Health Thank You Day", November 21, 2016. Health 2016-11-15 2016-11-15 Referred to the House Committee on Energy and Commerce. House Rep. Wittman, Robert J. [R-VA-1] VA R W000804 4 Expresses the sense of Congress that public health professionals are to be celebrated, commended, and thanked on Public Health Thank You Day for their profoundly important contributions to the nation. 2023-01-11T13:34:05Z  
114-s-3466 114 s 3466 Accelerating New Pharmaceutical Competition Act Health 2016-09-29 2016-09-29 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Paul, Rand [R-KY] KY R P000603 0 Accelerating New Pharmaceutical Competition Act This bill amends the Federal Food, Drug, and Cosmetic Act to permit brand name drug applications to rely upon investigations conducted in certain foreign countries if the drug has been approved in the foreign country where the investigations were conducted. The Food and Drug Administration (FDA) has 90 days to act on these applications. The bill revises a provision regarding the effective date of the approval of a generic drug that is subject to a patent infringement action. The FDA must prioritize the review of, and act within 150 days on, generic drug applications or supplements to generic drug applications for drugs: (1) for which there is a shortage, or (2) that have not been recently introduced to the market by more than one manufacturer and for which tentative approval has not been granted to more than two applications. 2023-01-11T13:34:07Z  
114-sres-590 114 sres 590 A resolution commemorating 100 years of health care services provided by Planned Parenthood. Health 2016-09-29 2016-09-29 Referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6273-6274; text of measure as introduced: CR S6273) Senate Sen. Wyden, Ron [D-OR] OR D W000779 24 Expresses support for the preventive services that Planned Parenthood Federation of America doctors, nurses, and staff provide to patients. Recognizes that Planned Parenthood is a safety net provider that reaches medically underserved people. Declares that Planned Parenthood should not be defunded, attacked, or discriminated against for being a women's health care provider. 2023-01-11T13:34:05Z  
114-sres-591 114 sres 591 A resolution designating the week of October 9 through October 15, 2016, as "National Case Management Week" to recognize the role of case management in improving health care outcomes for patients. Health 2016-09-29 2016-09-29 Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6256-6257; text as passed Senate: CR S6274) Senate Sen. Boozman, John [R-AR] AR R B001236 2 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Designates the week of October 9-October 15, 2016, as National Case Management Week. Recognizes the role of case management in providing successful and cost-effective health care. 2018-06-02T06:22:05Z  
114-sres-592 114 sres 592 A resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease. Health 2016-09-29 2016-09-29 Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6256-6257; text as passed Senate: CR S6274) Senate Sen. Scott, Tim [R-SC] SC R S001184 3 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Expresses support for the goals and ideals of Sickle Cell Disease Awareness Month. (Sickle cell disease is an inherited blood disorder than can lead to pain, anemia, infections, and stroke.) Encourages people to hold events and activities to raise awareness of preventive care programs, treatments, and other patient services for those suffering from sickle cell disease. 2021-07-10T19:48:59Z  
114-sres-593 114 sres 593 A resolution designating September 22, 2016, as "National Falls Prevention Awareness Day" to raise awareness and encourage the prevention of falls among older adults. Health 2016-09-29 2016-09-29 Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6256-6257; text as passed Senate: CR S6274-6275) Senate Sen. Collins, Susan M. [R-ME] ME R C001035 1 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Designates September 22, 2016, as National Falls Prevention Awareness Day. Recognizes that there are cost-effective falls prevention programs and policies. Commends the Falls Free Coalition and others for their efforts to increase awareness of falls prevention. Recognizes the: (1) Centers for Disease Control and Prevention for its work to make falls prevention a routine part of clinical care, and (2) Administration for Community Living for its work to promote access to evidence-based programs and services. 2018-06-02T06:22:05Z  
114-sres-596 114 sres 596 A resolution designating September 2016 as "Pulmonary Fibrosis Awareness Month". Health 2016-09-29 2016-09-29 Referred to the Committee on the Judiciary. (text of measure as introduced: CR S6276) Senate Sen. Coons, Christopher A. [D-DE] DE D C001088 2 Designates September 2016 as Pulmonary Fibrosis Awareness Month. (Pulmonary fibrosis is scarring of the lungs that causes breathing problems.) Expresses continued support for more robust and accelerated research to develop more effective treatments for pulmonary fibrosis and to ultimately find a cure for the disease. Recognizes the courage and contributions of individuals with pulmonary fibrosis who participate in clinical trials. Commends the dedication of those working to improve the quality of life of individuals with pulmonary fibrosis and the families of those individuals. 2023-01-11T13:34:05Z  
114-sres-601 114 sres 601 A resolution designating September 2016 as "National Dystonia Awareness Month" and raising awareness and understanding of the disorder of dystonia. Health 2016-09-29 2016-09-29 Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6286; text as passed Senate: CR S6277-6278) Senate Sen. Isakson, Johnny [R-GA] GA R I000055 1 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Designates September 2016 as National Dystonia Awareness Month. (Dystonia is a neurological disorder that is characterized by repetitive, involuntary muscle contractions.) Recognizes the need for additional research to find a cure for dystonia. Encourages people and groups to support National Dystonia Awareness Month through ceremonies and activities to promote public awareness of dystonia and foster the understanding of the impact of dystonia on patients and their families. 2021-07-10T19:49:01Z  
114-sres-604 114 sres 604 A resolution expressing support for the designation of November 2016 as "National Bladder Health Month". Health 2016-09-29 2016-11-17 Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. Senate Sen. Kirk, Mark Steven [R-IL] IL R K000360 0 (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Expresses support for the designation of November 2016 as National Bladder Health Month. 2023-01-11T13:34:05Z  
114-hr-6199 114 hr 6199 Investing in Testing Act of 2016 Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Maloney, Sean Patrick [D-NY-18] NY D M001185 0 Investing in Testing Act of 2016 This bill requires the Centers for Disease Control and Prevention to study the health implications of contamination of drinking water by per- and polyfluoroalkyl substances (PFASs). (PFASs can accumulate in the body and are commonly found at low levels in food, water, and the environment.) 2023-01-11T13:33:42Z  
114-hr-6215 114 hr 6215 Medicaid Gap Relief Act of 2016 Health 2016-09-28 2016-10-06 Referred to the Subcommittee on Health. House Rep. Veasey, Marc A. [D-TX-33] TX D V000131 0 Medicaid Gap Relief Act of 2016 This bill amends the Internal Revenue Code to exempt certain low-income residents of states that have not expanded Medicaid under the Patient Protection and Affordable Care Act (ACA) from the ACA's individual mandate to maintain health insurance coverage. 2023-01-11T13:33:42Z  
114-hr-6224 114 hr 6224 Enhancing Minority and Women Representation in NIH Medical Research Act of 2016 Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Beatty, Joyce [D-OH-3] OH D B001281 6 Enhancing Minority and Women Representation in NIH Medical Research Act of 2016 This bill amends the Public Health Service Act to require the National Institutes of Health (NIH), in assessing research priorities, to publish data on certain clinical research study populations. The NIH must foster collaboration among clinical research projects that use human subjects and that collect similar data to increase the number and diversity of subjects. The strategic plans of the national research institutes must ensure that future activities take into account women and minorities and are focused on reducing health disparities. Advisory council reports must include certain demographic data for clinical research subjects. The results of NIH-funded clinical trials that include women and minorities must be submitted to NIH's clinical trial data bank. The National Institute on Minority Health and Health Disparities may foster partnerships among the national research institutes and encourage the funding of collaborative research projects to achieve NIH goals related to minority health and health disparities. The NIH must develop policies for NIH-funded basic research projects to assess how differences between male and female cells, tissues, or animals may be examined and analyzed. 2023-01-11T13:33:41Z  
114-hr-6226 114 hr 6226 PUSH Act of 2016 Health 2016-09-28 2016-10-06 Referred to the Subcommittee on Health. House Rep. Price, Tom [R-GA-6] GA R P000591 20 Pre-Claims Undermine Seniors' Health Act of 2016 or the PUSH Act of 2016 This bill delays the Medicare demonstration for pre-claim review of home health services and requires the Centers for Medicare & Medicaid Services (CMS) to report on such pre-claim review. Specifically, CMS shall delay or suspend the demonstration by the later of: (1) one year after either the bill's enactment or the demonstration's scheduled start-date, as applicable; or (2) six months after CMS submits its report.  2023-01-11T13:33:41Z  
114-hr-6229 114 hr 6229 MISSION ZERO Act Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Burgess, Michael C. [R-TX-26] TX R B001248 3 Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act or the MISSION ZERO Act This bill amends the Public Health Service Act to require the Office of the Assistant Secretary for Preparedness and Response to award grants to certain trauma centers to enable military trauma care providers and trauma teams to provide trauma care and related acute care at those trauma centers. Funds may be used to train and incorporate military trauma care providers into the trauma center, including expenditures for malpractice insurance, office space, information technology, specialty education and supervision, trauma programs, and state license fees. Grantees must allow the military trauma care providers to be deployed for military operations, training, or response to a mass casualty incident. 2023-01-11T13:33:41Z  
114-hr-6241 114 hr 6241 Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2016 Health 2016-09-28 2016-09-28 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. DeSantis, Ron [R-FL-6] FL R D000621 1 Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to establish a reciprocal marketing approval process that allows for the sale of a drug, biological product, or medical device that has not been approved by the Food and Drug Administration (FDA) if the product is approved for sale in another country. For a product to be granted reciprocal marketing approval, the product's sponsor must submit a request to the FDA that demonstrates: (1) the product may be sold in at least one country from a specified list of countries, (2) the FDA and listed countries have not withdrawn approval of the product because of safety or effectiveness concerns, and (3) there is a public health or unmet medical need for the product. The FDA may: (1) require postmarket studies of a product granted reciprocal marketing approval, or (2) decline to approve a product that is not safe and effective. The FDA must grant or decline reciprocal marketing approval not later than 30 days after receiving a request. During that period, the FDA and product sponsor must negotiate and finalize product labeling and, for a medical device, classify the device. Congress may pass a joint resolution to grant reciprocal marketing approval to a product that the FDA declines to approve through this process. User fees apply to requests for reciprocal marketing approval. The FDA must encourage the sponsors of potentially eligible products to request reciprocal marketing approval. 2023-01-11T13:33:41Z  
114-hr-6259 114 hr 6259 Protecting Our Kids' Medicine Act of 2016 Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Israel, Steve [D-NY-3] NY D I000057 0 Protecting Our Kids' Medicine Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of liquid formulations of over-the-counter drugs that are not packaged with a dosage delivery device, such as a calibrated cup or spoon, and that do not have measurements on the label and on the dosage delivery device exclusively in metric units. The Food and Drug Administration may waive the requirement for metric units if that requirement would not benefit public health. Over-the-counter liquid drugs labeled for pediatric use may not be sold without a flow restrictor or another mechanism to reduce accidental ingestion. 2023-01-11T13:33:40Z  
114-hr-6261 114 hr 6261 ACO Assignment Improvement Act of 2016 Health 2016-09-28 2016-10-07 Referred to the Subcommittee on Health. House Rep. Kilmer, Derek [D-WA-6] WA D K000381 1 ACO Assignment Improvement Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to establish additional requirements for assigning Medicare fee-for-service beneficiaries to accountable care organizations (ACOs) under the Medicare shared savings program. (The program enables ACOs to receive payments for savings stemming from care coordination and management.) Specifically, the bill requires the basis for assignment to reflect beneficiaries' utilization of not only primary care services provided by ACO physicians, but also those provided by other ACO practitioners. Other ACO practitioners include physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, certified nurse-midwives, clinical social workers, clinical psychologists, and registered dieticians or nutrition professionals. 2023-01-11T13:33:40Z  
114-hr-6265 114 hr 6265 Medigap Consumer Protection Act of 2016 Health 2016-09-28 2016-10-07 Referred to the Subcommittee on Health. House Rep. McDermott, Jim [D-WA-7] WA D M000404 3 Medigap Consumer Protection Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to: (1) expand guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies), (2) eliminate certain limitations on Medigap policies for newly eligible Medicare beneficiaries, and (3) modify other provisions related to Medigap policies. ("Guaranteed issue" rights require that a policy be offered to any eligible applicant without regard to health status.) 2023-01-11T13:33:40Z  
114-hr-6269 114 hr 6269 Ban Poisonous Additives Act of 2016 Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Meng, Grace [D-NY-6] NY D M001188 1 Ban Poisonous Additives Act of 2016 This bill bans food containers composed, in whole or in part, of bisphenol A (BPA). The Food and Drug Administration (FDA) may grant waivers to a facility for a particular product if the facility: (1) demonstrates that it is not technologically feasible to replace BPA in the container or to use a BPA-free container, and (2) submits to the FDA a plan and time line for removing BPA from the container. Products granted a waiver must include a warning on the label. The FDA must promote and facilitate the use of BPA replacements. BPA may not be replaced with substances that: (1) are known or likely human carcinogens; (2) have been found by the Environmental Protection Agency (EPA) to be persistent, bioaccumulative, and toxic; (3) cause reproductive or developmental toxicity; or (4) are endocrine disrupting chemicals. The FDA must review substances that may be found in food, including food additives and food contact substances, and take remedial action if it does not determine that there is a reasonable certainty that no harm will result from aggregate exposure, taking into consideration potential adverse effects from low-dose exposure and the effects on vulnerable populations and populations with high exposure. This bill amends the Federal Food, Drug, and Cosmetic Act to require the manufacturer or supplier of a food contact substance to notify the FDA of the identity and intended use of the substance prior to its introduction into interstate commerce and that: (1) no adverse health effects result from low-dose exposures to the substance, and (2) the substance has not been shown to cause reproductive or developmental toxicity in humans or animals. 2023-01-11T13:33:40Z  
114-hr-6274 114 hr 6274 Hospital Outcomes Act of 2016 Health 2016-09-28 2016-10-07 Referred to the Subcommittee on Health. House Rep. Paulsen, Erik [R-MN-3] MN R P000594 2 Hospital Outcomes Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to replace the existing methodology for calculating Medicare payment adjustments for subsection (d) hospitals based on outcomes in readmissions and complications with a new methodology based on potentially avoidable outcomes in those areas. (In general, a "subsection (d) hospital" is an acute care hospital that receives payments under Medicare's inpatient prospective payment system.) The bill: (1) establishes a methodology for determining a hospital's financial impact attributable to potentially avoidable outcomes performance with regard to complications and readmissions, and (2) requires the Centers for Medicare & Medicaid Services (CMS) to select methodologies for identifying potentially avoidable outcomes in these categories. Subject to both a ceiling and a floor, a hospital's payment adjustment factor for an applicable prospective period shall be based on the ratio of the hospital's financial impact to the aggregate amount of standardized payments made to the hospital with respect to that period. CMS must ensure budget neutrality with respect to application of the payment adjustment factor across all subsection (d) hospitals. CMS shall regularly report to hospitals and to the public on each hospital's performance with regard to potentially avoidable outcomes. 2023-01-11T13:33:39Z  
114-hr-6275 114 hr 6275 Donald Payne Sr. Colorectal Cancer Detection Act of 2016 Health 2016-09-28 2016-10-07 Referred to the Subcommittee on Health. House Rep. Payne, Donald M., Jr. [D-NJ-10] NJ D P000604 7 Donald Payne Sr. Colorectal Cancer Detention Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage and payment, subject to specified frequency limits, of certain colorectal cancer screening blood-based tests. 2023-01-11T13:33:39Z  
114-hr-6284 114 hr 6284 EPI Act Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Smith, Adam [D-WA-9] WA D S000510 0 Eliminate Price Increases Act of 2016 or the EPI Act This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer. 2023-01-11T13:33:39Z  
114-hres-899 114 hres 899 Expressing support for a stable and sustainable funding source for the Teaching Health Center Graduate Medical Education (THCGME) Program. Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Reichert, David G. [R-WA-8] WA R R000578 16 Expresses the sense of the House of Representatives that the Teaching Health Center Graduate Medical Education (THCGME) Program should be protected and sustained. (The THCGME Program awards grants to health centers for primary care residency programs.) 2023-01-11T13:33:36Z  
114-hres-903 114 hres 903 Expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease. Health 2016-09-28 2016-09-28 Referred to the House Committee on Oversight and Government Reform. House Rep. Davis, Danny K. [D-IL-7] IL D D000096 1 Expresses support for the goals and ideals of Sickle Cell Disease Awareness Month. (Sickle cell disease is an inherited blood disorder than can lead to pain, anemia, infections, and stroke.) Encourages people to hold events and activities to raise awareness of preventive care programs, treatments, and other patient services for those suffering from sickle cell disease. 2023-01-11T13:33:36Z  
114-hres-904 114 hres 904 Honoring Sisters Network Inc.® for its work to raise awareness about the tragic impact of breast cancer in the African-American community. Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Green, Al [D-TX-9] TX D G000553 0 Honors Sisters Network Inc. for raising awareness about the impact of breast cancer in the African-American community. (African Americans are more likely to die from breast cancer than members of other racial groups.) 2023-01-11T13:33:36Z  
114-hres-906 114 hres 906 Supporting the goals and ideals of Red Ribbon Week during the period of October 23 through October 31, 2016. Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Guinta, Frank C. [R-NH-1] NH R G000570 1 Expresses support for the goals and ideals of Red Ribbon Week. Encourages: (1) children, teens, and other individuals to choose to live drug-free lives, and (2) people to promote drug-free communities and to participate in drug prevention activities. 2023-01-11T13:33:36Z  
114-hres-914 114 hres 914 Expressing support for designation of September 2016 as "Pulmonary Fibrosis Awareness Month". Health 2016-09-28 2016-09-28 Referred to the House Committee on Energy and Commerce. House Rep. Paulsen, Erik [R-MN-3] MN R P000594 1 Supports the designation of Pulmonary Fibrosis Awareness Month. (Pulmonary fibrosis is scarring of the lungs that causes breathing problems.) Expresses continued support for more robust and accelerated research to develop more effective treatments for pulmonary fibrosis and to ultimately find a cure for the disease. Recognizes the courage and contributions of individuals with pulmonary fibrosis who participate in clinical trials. Commends the dedication of those working to improve the quality of life of individuals with pulmonary fibrosis and the families of those individuals. 2023-01-11T13:33:36Z  
114-s-3407 114 s 3407 MISSION ZERO Act Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Kirk, Mark Steven [R-IL] IL R K000360 3 Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths Act or the MISSION ZERO Act This bill amends the Public Health Service Act to require the Office of the Assistant Secretary for Preparedness and Response to award grants to certain trauma centers to enable military trauma care providers and trauma teams to provide trauma care and related acute care at those trauma centers. Funds may be used to train and incorporate military trauma care providers into the trauma center, including expenditures for malpractice insurance, office space, information technology, specialty education and supervision, trauma programs, and state license fees. Grantees must allow the military trauma care providers to be deployed for military operations, training, or response to a mass casualty incident. 2023-01-11T13:33:32Z  
114-s-3412 114 s 3412 Ban Poisonous Additives Act of 2016 Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Markey, Edward J. [D-MA] MA D M000133 0 Ban Poisonous Additives Act of 2016 This bill bans food containers composed, in whole or in part, of bisphenol A (BPA). The Food and Drug Administration (FDA) may grant waivers to a facility for a particular product if the facility: (1) demonstrates that it is not technologically feasible to replace BPA in the container or to use a BPA-free container, and (2) submits to the FDA a plan and time line for removing BPA from the container. Products granted a waiver must include a warning on the label. The FDA must promote and facilitate the use of BPA replacements. BPA may not be replaced with substances that: (1) are known or likely human carcinogens; (2) have been found by the Environmental Protection Agency (EPA) to be persistent, bioaccumulative, and toxic; (3) cause reproductive or developmental toxicity; or (4) are endocrine disrupting chemicals. The FDA must review substances that may be found in food, including food additives and food contact substances, and take remedial action if it does not determine that there is a reasonable certainty that no harm will result from aggregate exposure, taking into consideration potential adverse effects from low-dose exposure and the effects on vulnerable populations and populations with high exposure. This bill amends the Federal Food, Drug, and Cosmetic Act to require the manufacturer or supplier of a food contact substance to notify the FDA of the identity and intended use of the substance prior to its introduction into interstate commerce and that: (1) no adverse health effects result from low-dose exposures to the substance, and (2) the substance has not been shown to cause reproductive or developmental toxicity in humans or animals. 2023-01-11T13:33:31Z  
114-s-3431 114 s 3431 Scleroderma and Fibrosis Research Enhancement Act of 2016 Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Gillibrand, Kirsten E. [D-NY] NY D G000555 2 Scleroderma and Fibrosis Research Enhancement Act of 2016 This bill requires the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to establish the National Commission on Scleroderma and Fibrosis Research. (Scleroderma and fibrosis are connective tissue conditions that cause hardening or scarring of skin and organs.) The commission must develop a long-term, comprehensive plan for scleroderma and fibrosis research. The plan must: (1) prioritize research that has cross-cutting value and requires coordination across NIH, and (2) include specific steps for implementation of the research. The commission must establish working groups to make research recommendations for the various organs and systems impacted by fibrotic illness. The commission must be terminated not later than two years after establishment. The NIAMS must create the Scleroderma and Fibrosis Working Group to oversee and assist with implementation of the long-term plan. 2023-01-11T13:33:31Z  
114-s-3435 114 s 3435 Craig Thomas Rural Hospital and Provider Equity Act of 2016 Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Finance. Senate Sen. Roberts, Pat [R-KS] KS R R000307 4 Craig Thomas Rural Hospital and Provider Equity Act of 2016 This bill amends the Public Health Service Act and title XVIII (Medicare) of the Social Security Act to: establish, extend, reinstate, or modify various Medicare payment adjustments for rural hospitals; establish a capital infrastructure revolving loan program for rural medical facilities; allow authorized physician assistants to order hospice care under Medicare; establish Medicare coverage for specified mental health counselor services and marriage and family therapist services; create a grant program for state offices of rural health; and modify other provisions related to rural medical facilities.  2023-01-11T13:33:30Z  
114-s-3454 114 s 3454 A bill to improve medication adherence. Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Finance. Senate Sen. Carper, Thomas R. [D-DE] DE D C000174 1 This bill amends the Public Health Service Act to require the Department of Health and Human Services to research and report on medication adherence with respect to federal health care programs. ("Medication adherence" refers to the extent to which patients take their medications as prescribed.) In addition, the bill amends titles XI (General Provisions) and XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services to: upon request by a prescription drug plan (PDP) sponsor, provide the plan with Medicare enrollee claims data to provide context for an enrollee's medication regimen; in calculating the minimum medical loss ratio with respect to PDPs, include medication management as an activity that improves health care quality; and through the Center for Medicare and Medicaid Innovation, test a model for enhanced medication therapy management for PDPs under Medicare Advantage. 2023-01-11T13:33:30Z  
114-s-3455 114 s 3455 Pharmaceutical Supply and Value Enhancement Act Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Klobuchar, Amy [D-MN] MN D K000367 1 Pharmaceutical Supply and Value Enhancement Act or the Pharmaceutical SAVE Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to authorize importation of life-saving drugs for which there is, or is likely to be, a shortage. For a drug to be imported, the drug's manufacturer must intend to seek FDA approval of the drug as a generic drug. The FDA may deny importation of a drug for reasons related to safety or effectiveness. Drugs in noncompetitive markets must be treated as being in a shortage for purposes of this bill and for purposes of expedited inspections and review. A drug is in a noncompetitive market if: (1) there are fewer than five holders of approved applications for commercially available brand name or generic versions of the drug, (2) the drug has been approved for at least 10 years, and (3) patents on the active ingredient of the drug have expired. 2023-01-11T13:33:30Z  
114-s-3457 114 s 3457 Reducing Medicare Costs through Innovation Act Health 2016-09-28 2016-09-28 Read twice and referred to the Committee on Finance. Senate Sen. Gardner, Cory [R-CO] CO R G000562 1 Reducing Medicare Costs through Innovation Act This bill establishes a Medicare commercialization grant program, through which the Centers for Medicare & Medicaid Services (CMS) shall award grants to eligible small businesses for certain activities related to developing novel eligible medical products and receiving Food and Drug Administration (FDA) approval for such products. CMS shall solicit grant applications annually, with a focus on the diseases or conditions that are the top ten cost drivers in the Medicare program. To carry out the grant program, CMS shall use amounts allocated under the Small Business Act for the Small Business Innovation Research and Small Business Technology Transfer programs. The bill also establishes a pilot program (similar to a pilot program that was previously established in regulation) for parallel review of medical products with the purpose of reducing, with respect to certain medical products developed by Medicare commercialization grant recipients, the timeline for FDA approval and Medicare national coverage determinations. A Medicare commercialization grant applicant may choose to apply for FDA approval of novel medical products either through a traditional process or through the pilot program. 2023-01-11T13:33:30Z  
114-hr-6174 114 hr 6174 Closing Loopholes for Orphan Drugs Act Health 2016-09-27 2016-09-27 Referred to the House Committee on Energy and Commerce. House Rep. Welch, Peter [D-VT-At Large] VT D W000800 2 Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program. 2023-01-11T13:33:43Z  
114-hr-6184 114 hr 6184 Medicare Enrollment Protection Act Health 2016-09-27 2016-10-04 Referred to the Subcommittee on Health. House Rep. Dold, Robert J. [R-IL-10] IL R D000613 3 Medicare Enrollment Protection Act This bill amends title XVIII (Medicare) of the Social Security Act to: (1) create a special Medicare enrollment period for individuals enrolled in, or transitioning out of, continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA); and (2) exempt such individuals from certain monthly premium increases associated with delaying Medicare coverage. 2023-01-11T13:33:43Z  
114-hr-6185 114 hr 6185 Ellie's Law Health 2016-09-27 2016-09-27 Referred to the House Committee on Energy and Commerce. House Rep. Clarke, Yvette D. [D-NY-9] NY D C001067 1 Ellie Helton, Lisa Colagrossi, Teresa Anne Lawrence, and Jennifer Sedney Focused Research Act or Ellie's Law This bill authorizes the National Institute of Neurological Disorders and Stroke to conduct or support research on unruptured brain aneurysms in a patient population diversified by age, sex, and race. 2023-01-11T13:33:43Z  
114-hr-6120 114 hr 6120 SPARC Act Health 2016-09-22 2016-09-30 Referred to the Subcommittee on Health. House Rep. Murphy, Tim [R-PA-18] PA R M001151 1 Secondary Payer Advancement, Rationalization, and Clarification Act or the SPARC Act This bill amends title XVIII (Medicare) of the Social Security Act to specify recovery rules with respect to secondary claims responsibility under the Medicare prescription drug benefit. Under current law, secondary payor provisions apply under the benefit in the same manner as they apply with respect to Medicare Advantage plans. 2023-01-11T13:33:45Z  
114-hr-6139 114 hr 6139 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016 Health 2016-09-22 2016-09-29 Referred to the Subcommittee on Health. House Rep. Burgess, Michael C. [R-TX-26] TX R B001248 20 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2016 This bill amends titles II (Old Age, Survivors, and Disability Insurance) and XVIII (Medicare) of the Social Security Act to indefinitely extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients. Under current law, such coverage is limited to 36 months following a transplant. 2023-01-11T13:33:44Z  
114-hr-6142 114 hr 6142 Fruit Labeling Accuracy Act of 2016 Health 2016-09-22 2016-09-22 Referred to the House Committee on Energy and Commerce. House Rep. Duffy, Sean P. [R-WI-7] WI R D000614 14 Fruit Labeling Accuracy Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the Food and Drug Administration from requiring the percent daily value of added sugars to appear on the label of dried fruit or vegetables that are naturally low in sugar or juice beverages made from fruit or vegetables that are naturally low in sugar. 2023-01-11T13:33:44Z  
114-hres-883 114 hres 883 Supporting the designation of a week as National Federal Nurse Recognition Week. Health 2016-09-22 2016-09-22 Referred to the House Committee on Energy and Commerce. House Rep. Schakowsky, Janice D. [D-IL-9] IL D S001145 4 Expresses support for the designation of National Federal Nurse Recognition Week. Recognizes the dedication and vital role of federal nurses and the need to maintain an adequate number of well-trained federal nurses. Commends federal nurses as integral in supporting the government's mission to provide quality, accessible, and affordable health care. 2023-01-11T13:33:37Z  
114-hres-887 114 hres 887 Supporting efforts to increase competition and accountability in the health insurance marketplace, and to extend accessible, quality, affordable health care coverage to every American through the choice of a public insurance plan. Health 2016-09-22 2016-09-22 Referred to the House Committee on Energy and Commerce. House Rep. DeFazio, Peter A. [D-OR-4] OR D D000191 14 Expresses support for efforts to build on the Patient Protection and Affordable Care Act by ensuring that individuals have access to a public health insurance option. 2023-01-11T13:33:37Z  
114-hres-888 114 hres 888 Expressing support for designation of September as "National Childhood Obesity Awareness Month". Health 2016-09-22 2016-09-22 Referred to the House Committee on Energy and Commerce. House Rep. Fudge, Marcia L. [D-OH-11] OH D F000455 3 Expresses support for the designation of National Childhood Obesity Awareness Month. Recognizes the importance of preventing childhood obesity and decreasing its prevalence in the United States. 2023-01-11T13:33:37Z  
114-s-3387 114 s 3387 SAVINGS Act Health 2016-09-22 2016-09-22 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Cotton, Tom [R-AR] AR R C001095 0 Safely Advancing Valuable and Inexpensive New Generic Solutions Act or the SAVINGS Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to prioritize the review of certain generic drug applications and act on them within 150 days. This generic fast track review applies to applications for drugs: (1) that are not under patent or for which patents will expire soon, (2) for which there is no marketing exclusivity in effect, and (3) for which a generic has not recently been introduced to the market by more than one manufacturer. The FDA must report on applications subject to generic fast track review and provide an annual accounting of how it has spent generic drug user fees. 2023-01-11T13:33:32Z  
114-s-3392 114 s 3392 Local Coverage Determination Clarification Act of 2016 Health 2016-09-22 2016-09-22 Read twice and referred to the Committee on Finance. Senate Sen. Isakson, Johnny [R-GA] GA R I000055 2 Local Coverage Determination Clarification Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to revise the process by which Medicare administrative contractors (MACs) issue and reconsider local coverage determinations (LCDs) that: (1) are new, (2) restrict or substantively revise existing LCDs, or (3) are otherwise specified in regulation. (MACs are private insurers that process Medicare claims within specified geographic areas.) Before such an LCD may take effect, the MAC issuing the determination must, with respect to each geographic area to which the determination applies: publish online a proposed version of the determination and other specified, related information; convene one or more public meetings to review the draft determination, receive comments, and secure the advice of an expert panel; post online a record of the minutes from each such meeting; provide a period for submission of written public comments; and post online specified information related to the rationale for the final determination. Upon the filing of an applicable request by an interested party with regard to the reconsideration of a specified LCD, the MAC that issued the determination shall: provide specified information related to whether the determination failed to correctly apply qualifying relevant evidence, exceeds the scope of its intended purpose, fails to apply as intended, or is otherwise erroneous; preserve the determination, modify the determination, or rescind the determination in part; and make publicly available a written description of such action. An interested party may appeal a reconsideration decision to the Centers for Medicare & Medicaid Services (CMS). CMS shall appoint a Medicare Reviews and Appeals Ombudsman to carry out specified duties with regard to LCDs. 2023-01-11T13:33:32Z  
114-hr-6101 114 hr 6101 ACO Improvement Act of 2016 Health 2016-09-21 2016-09-28 Referred to the Subcommittee on Health. House Rep. Black, Diane [R-TN-6] TN R B001273 1 ACO Improvement Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to allow an accountable care organization (ACO) to: (1) reduce or eliminate certain cost-sharing for primary care services provided within the ACO's network; (2) develop incentives to encourage patient engagement; (3) elect prospective assignment of Medicare fee-for-service beneficiaries; and (4) if specified requirements are met, distribute internal cost savings. The Centers for Medicare & Medicaid Services (CMS) shall waive specified regulatory requirements for ACOs that have elected to share in both savings and losses under a "two-sided risk model." In addition, the bill: (1) requires CMS to waive, with respect to certain ACOs, specified limitations regarding telehealth services; (2) allows certain ACOs to depart slightly from specified minimum enrollment requirements; (3) requires CMS to establish a demonstration project for allowing growth of certain prospective risk scores; (4) and allows CMS to make permanent certain ACO-related pilot programs that have been successful. 2023-01-11T13:33:46Z  
114-hr-6109 114 hr 6109 Medicare Affordability and Enrollment Act of 2016 Health 2016-09-21 2016-09-28 Referred to the Subcommittee on Health. House Rep. Pallone, Frank, Jr. [D-NJ-6] NJ D P000034 4 Medicare Affordability and Enrollment Act of 2016 This bill amends titles XVIII (Medicare) and XIX (Medicaid) of the Social Security Act to: establish an annual limit on out-of-pocket expenditures for Medicare fee-for-service beneficiaries; expand income-eligibility for cost-sharing and, with respect to beneficiaries consequently eligible for cost-sharing, establish a federal medical assistance percentage of 100% under Medicaid; limit the amount of coinsurance or copayment required of low-income beneficiaries; eliminate the two-year waiting period for Medicare coverage with respect to individuals with disabilities; allow beneficiaries residing in U.S. territories to be eligible for certain premium and cost-sharing subsidies available to other beneficiaries under the Medicare prescription drug benefit; and modify other provisions related to special rules for beneficiaries in Puerto Rico, income and resource determinations, and enrollment procedures. The bill also amends the Medicare Improvements for Patients and Providers Act of 2008 to extend funding for specified beneficiary outreach and education activities. 2023-01-11T13:33:45Z  
114-s-3371 114 s 3371 Medicare Affordability and Enrollment Act of 2016 Health 2016-09-21 2016-09-21 Read twice and referred to the Committee on Finance. Senate Sen. Wyden, Ron [D-OR] OR D W000779 6 Medicare Affordability and Enrollment Act of 2016 This bill amends titles XVIII (Medicare) and XIX (Medicaid) of the Social Security Act to: establish an annual limit on out-of-pocket expenditures for Medicare fee-for-service beneficiaries; expand income-eligibility for cost-sharing and, with respect to beneficiaries consequently eligible for cost-sharing, establish a federal medical assistance percentage of 100% under Medicaid; limit the amount of coinsurance or copayment required of low-income beneficiaries; eliminate the two-year waiting period for Medicare coverage with respect to individuals with disabilities; allow beneficiaries residing in U.S. territories to be eligible for certain premium and cost-sharing subsidies available to other beneficiaries under the Medicare prescription drug benefit; and modify other provisions related to special rules for beneficiaries in Puerto Rico, income and resource determinations, and enrollment procedures. The bill also amends the Medicare Improvements for Patients and Providers Act of 2008 to extend funding for specified beneficiary outreach and education activities. 2023-01-11T13:33:33Z  
114-hr-6083 114 hr 6083 Patient Navigation Assistance Act of 2016 Health 2016-09-20 2016-09-20 Referred to the House Committee on Energy and Commerce. House Rep. Israel, Steve [D-NY-3] NY D I000057 0 Patient Navigation Assistance Act of 2016 This bill amends title XIX (Medicaid) of the Social Security Act to require state Medicaid programs to provide medical assistance for patient navigator services. ("Patient navigators" are individuals who are trained to facilitate the care of other individuals and who have direct knowledge of the communities they serve.) 2023-01-11T13:33:46Z  
114-hr-6084 114 hr 6084 Improving Cancer Treatment Education Act of 2016 Health 2016-09-20 2016-09-27 Referred to the Subcommittee on Health. House Rep. Israel, Steve [D-NY-3] NY D I000057 0 Improving Cancer Treatment Education Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to establish Medicare coverage with respect to comprehensive treatment education services for cancer patients. In addition, the bill requires the National Institutes of Health to expand, intensify, and coordinate research on cancer symptom management improvement. 2023-01-11T13:33:46Z  
114-hr-6088 114 hr 6088 Hospital Quality Rating Transparency Act of 2016 Health 2016-09-20 2016-09-28 Referred to the Subcommittee on Health. House Rep. Renacci, James B. [R-OH-16] OH R R000586 20 Hospital Quality Rating Transparency Act of 2016 This bill delays the date upon which the Department of Health and Human Services (HHS) may make Overall Hospital Quality Star Ratings for hospitals publicly available. With respect to such ratings, HHS shall: (1) make publicly available detailed information on the methodology used, (2) have the validity and accuracy of such methodology independently confirmed, and (3) provide a public comment period of specified duration. HHS may not make the ratings publicly available until the later of July 31, 2017, or the date upon which the bill's requirements are satisfied. In the event that such ratings have already been published on a specified website, HHS shall remove them and not republish them until the bill's requirements have been satisfied. 2023-01-11T13:33:46Z  
114-hres-874 114 hres 874 Expressing support for designation of the month of September as "Rheumatic Disease Awareness Month", in recognition of the costs imposed by rheumatic diseases, the need for increased medical research, and the quality care provided by trained rheumatologists. Health 2016-09-20 2016-09-20 Referred to the House Committee on Energy and Commerce. House Rep. McKinley, David B. [R-WV-1] WV R M001180 1 Expresses support for the designation of Rheumatic Disease Awareness Month in recognition of the costs imposed by rheumatic diseases, the need for increased medical research, and the care provided by rheumatologists. Encourages people to celebrate the contributions of researchers and health care providers in serving those living with rheumatic diseases and to support efforts to find a cure. 2023-01-11T13:33:37Z  
114-s-3360 114 s 3360 Youth Access to Sexual Health Services Act of 2016 Health 2016-09-20 2016-09-20 Read twice and referred to the Committee on Finance. Senate Sen. Hirono, Mazie K. [D-HI] HI D H001042 8 Youth Access to Sexual Health Services Act of 2016 This bill authorizes the Department of Health and Human Services to award grants to support the access of marginalized youth to sexual health services such as sexual health education and contraception. Marginalized youth are disadvantaged individuals under the age of 26. Grants may be awarded to state or local health or education agencies, public schools, nonprofit organizations, hospitals, Indian tribes, and tribal organizations. Grants may be used to: (1) provide sexual health information to marginalized youth, (2) promote effective communication regarding sexual health among marginalized youth, (3) promote and support opportunities for school-age parents, and (3) train individuals who work with marginalized youth to promote sexual health and the development of safe and supportive environments. Grants may not be used to provide access to health services that: (1) are medically unsound; (2) withhold sexual health-promoting or lifesaving information; (3) promote gender stereotypes; or (4) are insensitive or unresponsive to the needs of homosexual, bisexual, or transgender youth, sexually active youth, school-age parents, or survivors of sexual abuse or assault. Unobligated FY2017 appropriations for abstinence education are made available for these grants. 2023-01-11T13:33:33Z  
114-s-3361 114 s 3361 Pulmonary Hypertension Research and Diagnosis Act of 2016 Health 2016-09-20 2016-09-20 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Casey, Robert P., Jr. [D-PA] PA D C001070 1 Pulmonary Hypertension Research and Diagnosis Act of 2016 This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to establish the Interagency Pulmonary Hypertension Coordinating Committee. The committee must monitor research and annually summarize research and medical advances regarding pulmonary hypertension. The committee must develop a comprehensive strategic plan to improve health outcomes for individuals with pulmonary hypertension. The plan must include recommendations regarding pulmonary hypertension diagnosis, research, transplantation criteria, public awareness, and health care delivery. HHS must report on activities related to improving health outcomes for individuals with pulmonary hypertension. The report must include information regarding pulmonary hypertension epidemiology, treatment, support available to individuals, and research. 2023-01-11T13:33:33Z  
114-sres-570 114 sres 570 A resolution recognizing the importance of substance abuse disorder treatment and recovery in the United States. Health 2016-09-19 2016-09-19 Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5888) Senate Sen. Murphy, Christopher [D-CT] CT D M001169 7 Recognizes the importance of National Alcohol and Drug Addiction Recovery Month. Affirms the continued need to support substance use education, treatment, and research. Honors the achievements of individuals who are in recovery from substance use disorders. 2023-01-11T13:34:06Z  
114-hr-6035 114 hr 6035 Community Integration Act of 2016 Health 2016-09-15 2016-09-15 Referred to the House Committee on Energy and Commerce. House Rep. Cartwright, Matt [D-PA-17] PA D C001090 1 Community Integration Act of 2016 This bill amends title XIX (Medicaid) of the Social Security Act to require a state Medicaid program to, with respect to an individual who requires a level of care provided in a nursing facility, intermediate care facility for the developmentally disabled, institution for mental disease, or other similar setting: (1) provide the individual with the choice and equal opportunity to receive such care in a home- and community-based setting; and (2) meet specified requirements relating to the provision and availability of care in such a setting, including a requirement to develop a statewide plan to increase affordable and accessible housing for individuals with disabilities. 2023-01-11T13:33:48Z  
114-hr-6039 114 hr 6039 Graduate Opportunities in Medical Education Distribution Act of 2016 Health 2016-09-15 2016-09-20 Referred to the Subcommittee on Health. House Rep. Hardy, Cresent [R-NV-4] NV R H001070 2 Graduate Opportunities in Medical Education Distribution Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to redistribute unused residency positions for which graduate medical education costs are paid under Medicare. Specifically, the Centers for Medicare & Medicaid Services must: (1) reduce a hospital's resident limit by a specified amount if the hospital has unused residency positions and is not a rural hospital with fewer than 250 acute care inpatient beds, and (2) increase the resident limit for each qualifying hospital that applies for an increase. In aggregate, the number of increased positions shall equal the number of reduced positions. The bill establishes specified priorities and capacity considerations with respect to redistribution. 2023-01-11T13:33:48Z  
114-hr-6040 114 hr 6040 Zero Impacted Kids in America (ZIKA) Act Health 2016-09-15 2016-09-15 Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. House Rep. Rokita, Todd [R-IN-4] IN R R000592 0 Zero Impacted Kids in America (ZIKA) Act This bill provides FY2016 emergency supplemental appropriations to the Departments of State and Health and Human Services (HHS) to prevent, prepare for, and respond to the Zika virus and other infectious diseases. The bill specifies permissible uses for the funds and designates the funds as an emergency requirement, which exempts the funds from discretionary spending limits. The emergency funding is only available if the President also designates the amounts as an emergency requirement. The bill provides appropriations to HHS for: the Food and Drug Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Public Health and Social Services Emergency Fund. The bill amends the Public Health Service Act to permit Project BioShield to be used to support the advanced development and procurement of medical countermeasures to diagnose, mitigate, prevent, or treat harm from any infectious disease that may pose a threat to the public health. (Under current law, Project BioShield supports only countermeasures against specific chemical, biological, radiological, and nuclear terrorist threats.) The bill provides funds for HHS to award grants to U.S. territories (Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, and the Northern Mariana Islands) for the purpose of combating the Zika virus. The bill provides appropriations to the Department of State for: the Administration of Foreign Affairs, the U.S. Agency for International Development, Bilateral Economic Assistance, International Security Assistance, and Multilateral Assistance. This bill amends title XX (Block Grants to States for Social Services) of the Social Security Act to adjust the FY2017-FY2025 funding levels for the Social Services Block Grant Program. 2023-01-11T13:33:48Z  
114-hr-6043 114 hr 6043 Fair Accountability and Innovative Research Drug Pricing Act of 2016 Health 2016-09-15 2016-09-15 Referred to the House Committee on Energy and Commerce. House Rep. Schakowsky, Janice D. [D-IL-9] IL D S001145 18 Fair Accountability and Innovative Research Drug Pricing Act of 2016 This bill amends the Public Health Service Act to require manufacturers of certain drugs and biological products to report to the Department of Health and Human Services (HHS) price increases that result in a 10% or more increase in the price of a drug over a 12-month period. Reports are required for prescription drugs and drugs commonly administered in hospitals, except vaccines, drugs for rare conditions, and drugs with annual sales for Medicare and Medicaid enrollees of less than $1. Manufacturers that do not submit a required report are subject to a civil penalty. The Inspector General of HHS must review drug price information to determine compliance. Collected penalty funds must be used to carry out activities related to this reporting requirement and to improve consumer and provider information about drug value and drug price transparency. HHS must publish manufacturer reports, a summary of those reports, and supporting analyses. 2023-01-11T13:33:48Z  
114-hr-6051 114 hr 6051 Local Medicaid Enforcement Incentives Act of 2016 Health 2016-09-15 2016-09-15 Referred to the House Committee on Energy and Commerce. House Rep. Israel, Steve [D-NY-3] NY D I000057 0 Local Medicaid Enforcement Incentives Act of 2016 This bill requires the Centers for Medicare & Medicaid Services to award grants to states for the purpose of establishing or expanding programs that: (1) detect and prevent Medicaid fraud, waste, and abuse; (2) identify and recover overpayments resulting from such fraud, waste, or abuse; and (3) share recovered overpayments with localities that assist in detection, prevention, or recovery. 2023-01-11T13:33:47Z  
114-hr-6065 114 hr 6065 Synthetic Drug Overdose Prevention and Education Act Health 2016-09-15 2016-09-15 Referred to the House Committee on Energy and Commerce. House Rep. Velazquez, Nydia M. [D-NY-7] NY D V000081 4 Synthetic Drug Overdose Prevention and Education Act This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention (CDC) to study strategies for preventing and treating the use of synthetic recreational drugs, which are substances marketed for recreational use (regardless of claims to the contrary) that are analogous to a controlled substance and are not medications. The Department of Health and Human Services must coordinate with the Drug Enforcement Administration (DEA) to establish and maintain a database of synthetic recreational drugs. The database must be publicly available for use in preventing and treating the use of synthetic recreational drugs. The CDC, in collaboration with the Substance Abuse and Mental Health Services Administration, the National Institute on Drug Abuse, the National Institutes of Health, and the DEA, must develop and implement a national outreach campaign to educate law enforcement personnel, health care professionals, community members, and others about preventing and treating the use of substances similar to marijuana (cannabimimetic agents). The CDC may award grants to federally qualified health centers for public awareness programs regarding substances similar to marijuana. 2023-01-11T13:33:47Z  
114-s-3335 114 s 3335 Fair Accountability and Innovative Research Drug Pricing Act of 2016 Health 2016-09-15 2016-09-15 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Baldwin, Tammy [D-WI] WI D B001230 3 Fair Accountability and Innovative Research Drug Pricing Act of 2016 This bill amends the Public Health Service Act to require manufacturers of certain drugs and biological products to report to the Department of Health and Human Services (HHS) price increases that result in a 10% or more increase in the price of a drug over a 12-month period. Reports are required for prescription drugs and drugs commonly administered in hospitals, except vaccines, drugs for rare conditions, and drugs with annual sales for Medicare and Medicaid enrollees of less than $1. Manufacturers that do not submit a required report are subject to a civil penalty. The Inspector General of HHS must review drug price information to determine compliance. Collected penalty funds must be used to carry out activities related to this reporting requirement and to improve consumer and provider information about drug value and drug price transparency. HHS must publish manufacturer reports, a summary of those reports, and supporting analyses. 2023-01-11T13:33:34Z  
114-sres-561 114 sres 561 A resolution supporting efforts to increase competition and accountability in the health insurance marketplace, and to extend accessible, quality, affordable health care coverage to every American through the choice of a public insurance plan. Health 2016-09-15 2016-09-15 Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5848) Senate Sen. Merkley, Jeff [D-OR] OR D M001176 32 Expresses support for efforts to build on the Patient Protection and Affordable Care Act by ensuring that individuals have access to a public health insurance option. 2023-01-11T13:34:06Z  

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE legislation (
    bill_id TEXT PRIMARY KEY,
    congress INTEGER,
    bill_type TEXT,
    bill_number INTEGER,
    title TEXT,
    policy_area TEXT,
    introduced_date TEXT,
    latest_action_date TEXT,
    latest_action_text TEXT,
    origin_chamber TEXT,
    sponsor_name TEXT,
    sponsor_state TEXT,
    sponsor_party TEXT,
    sponsor_bioguide_id TEXT,
    cosponsor_count INTEGER DEFAULT 0,
    summary_text TEXT,
    update_date TEXT,
    url TEXT
);
CREATE INDEX idx_leg_congress ON legislation(congress);
CREATE INDEX idx_leg_type ON legislation(bill_type);
CREATE INDEX idx_leg_policy ON legislation(policy_area);
CREATE INDEX idx_leg_date ON legislation(introduced_date);
CREATE INDEX idx_leg_sponsor ON legislation(sponsor_name);
CREATE INDEX idx_leg_sponsor_bioguide ON legislation(sponsor_bioguide_id);
Powered by Datasette · Queries took 1726.687ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API